Neurocess
PrivateLast Round
Seed
Apr 5, 2021
Est. Valuation
$3.4M
Total Funding Raised
$250,000
Company Overview
Neurocess operates in Healthcare & Life Sciences and is based in London. Its latest recorded funding round was a Seed round in April 2021.
Neurocess is a health technology company that develops wearable EMG-based sensor networks to monitor muscle activity and athletic performance for professional athletes.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Sports & Fitness, Health IoT, Sensors, Sports Analytics
Business Model
B2B
Customer Profile
Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurocess Comparables
Compare Neurocess with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Kinvent | 67% | |
| Myontec | 48% | |
| Dorsavi Ltd | 46% |
For institutional investors. Book with your work email.
Neurocess Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Neurocess Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Diffusion Capital Partners | Seed |
| Growth Circuit Ventures | Seed |
| SOSV | Seed, Pre Seed |
| HAX | Seed, Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 5, 2021
$250K raised from SOSV and Diffusion Capital Partners.
For institutional investors. Book with your work email.
Neurocess Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurocess's valuation, stock price, and market status.
Is Neurocess a public or private company?
Neurocess is a private company.
What is the current stock price of Neurocess?
Neurocess is a private company, so its shares have no public market price. Caplight tracks Neurocess's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurocess worth (valuation)?
Neurocess's valuation is estimated at $3.4M based on funding round data.
Can I buy Neurocess stock?
Neurocess shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurocess's last funding round?
Neurocess's most recent funding round was Seed on April 5, 2021.
Who are the main investors in Neurocess?
Key investors in Neurocess include HAX.
Will Neurocess IPO soon?
No public IPO plans have been announced for Neurocess.
How can I track Neurocess secondary market activity?
Caplight tracks bids, offers, and trades in Neurocess's shares on secondary markets.